ArticleFrontiers in pharmacology2021

Preclinical Characterization of a Novel Anti-Cancer PD-L1 Inhibitor RPH-120.

Andrey Kulikov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.